Cannabis use linked to uncertain transitions in early psychosis care

Discharge From Coordinated Specialty Care: Timing, Reasons, and Predictors in a National Early Psychosis Network.

Psychiatric services (Washington, D.C.) โ€ข โ€ข Related
๐Ÿค–

AI Summary

This study examined when and why people leave coordinated specialty care (CSC) programs for first-episode psychosis. Among 701 participants followed for up to 36 months, 44% were discharged. Of those discharges, 55% were classified as ambiguous, 28% as adverse, and 17% as positive. The authors describe discharge as following different clinical and structural pathways rather than representing a single type of outcome.

Baseline cannabis use was associated with a higher risk of ambiguous discharge (hazard ratio 1.81), but the study does not show that cannabis caused people to leave care or had a direct effect on recovery. For people using cannabis while receiving early-psychosis services, the finding underscores the importance of discussing cannabis use openly with clinicians and maintaining support during transitions. The authors call for earlier engagement, better discharge documentation, and stronger continuity-of-care planning.

๐Ÿ’ก Key Findings

1
Over 36 months, 44% of participants were discharged from coordinated specialty care, with ambiguous discharges making up 55% of all discharges.
High
90%
2
Baseline cannabis use was associated with a higher risk of ambiguous discharge (hazard ratio 1.81); this association does not establish causation.
Good
75%
3
The study identified distinct clinical and structural pathways to discharge and supports stronger transition and continuity-of-care services for people experiencing early psychosis.
High
85%

๐Ÿ“„ Original Abstract

Retention in coordinated specialty care (CSC) is critical for optimizing outcomes of first-episode psychosis, yet discharge from CSC is heterogeneous and poorly characterized. This study aimed to examine the timing of, reasons for, and predictors of discharge in a large early psychosis intervention network. Data were drawn from the Academic-Community Early Psychosis Intervention Network. Participants (N=701) were followed for up to 36 months after CSC admission. Discharges were classified as positive, ambiguous, or adverse. Kaplan-Meier and competing-risk Cox models were used to examine time to discharge and baseline predictors, respectively. Over 36 months, 44% of participants were discharged. Ambiguous discharges were most common (55% of discharges), followed by adverse (28%) and positive (17%) discharges. Twenty-five percent of participants were discharged by 10 months. Positive discharge was associated with commercial insurance (hazard ratio [HR]=3.48, p=0.001) and weekly family contact (HR=3.96, p=0.02). A longer duration of untreated psychosis (HR=1.18, p=0.002), prior hospitalization (HR=1.66, p=0.03), and cannabis use (HR=1.81, p=0.005) increased the risk for ambiguous discharge, whereas living with family (HR=0.51, p=0.03) and older age (HR=0.93, p=0.008) were protective. Legal involvement increased the risk for adverse discharge (HR=2.40, p=0.02), whereas antipsychotic use at admission was protective (HR=0.55, p=0.02). Discharge from CSC programs reflects distinct clinical and structural pathways. Findings from this study highlight the need for early engagement strategies, improved discharge documentation, and strong transition supports to promote continuity of care in early psychosis services.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.